Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J.‐F. Stalder
Transition to Ustekinumab in Patients With Moderate-To-Severe Psoriasis and Inadequate Response to Methotrexate: A Randomized Clinical Trial (TRANSIT)
British Journal of Dermatology
Dermatology
Medicine
Related publications
Ustekinumab in Real-Life Practice: Experience in 116 Patients With Moderate-To-Severe Psoriasis
Acta Medica Portuguesa
Medicine
Characterization of Insufficient Responders to Ustekinumab in Patients With Moderate-To-Severe Psoriasis in the US Corrona Psoriasis Registry
Journal of Dermatological Treatment
Dermatology
Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-To-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
A Network Meta-Analysis of Randomized, Controlled Trials of Ustekinumab and Adalimumab for Moderate-To-Severe Psoriasis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Brodalumab in Patients Who Had Inadequate Response to Ustekinumab
British Journal of Dermatology
Dermatology
Medicine
Response to ‘Kidney Disease in Moderate-To-Severe Psoriasis: A Critical Appraisal’
British Journal of Dermatology
Dermatology
Medicine
New Polymorphisms Associated With Response to Anti-TNF Drugs in Patients With Moderate-To-Severe Plaque Psoriasis
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Oral Curcumin in the Treatment of Moderate to Severe Psoriasis Vulgaris: A Prospective Clinical Trial
Journal of the American Academy of Dermatology
Dermatology
Randomized, Controlled Study of Bleselumab (ASKP1240) Pharmacokinetics and Safety in Patients With Moderate-To-Severe Plaque Psoriasis
Biopharmaceutics and Drug Disposition
Medicine
Pharmacology
Pharmaceutical Science
